Zydus Lifesciences Ltd.

Zydus Lifesciences has received final approval from the United States Food and Drug Administration (USFDA) to market Ivermectin Cream, 1%. USRLD: Soolantra. Ivermectin Cream is a used for the treatment of inflammatory lesions of rosacea. The drug will be manufactured at the group’s topical manufacturing facility at Ahmedabad, India.

Ivermectin Cream had annual sales of $176 million in the United States according to IQVIA data (IQVIA MAT June 2022). The group now has 319 approvals and has so far filed over 420 ANDAs since the commencement of the filing process in FY 2003-04.

Zydus Lifesciences (formerly known as Cadila Healthcare) is an India-based pharmaceutical company. The company's subsidiaries include Zydus Wellness, Liva Pharmaceuticals, Biochem Pharmaceutical Industries, Zydus Technologies, German Remedies, Dialforhealth India, Dialforhealth Unity and Dialforhealth Greencross, among others.